The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions

Autores
Mattiazzi, Alicia Ramona; Mundiña-Weilenmann, Cecilia; Vittone, Leticia; Said, María Matilde; Kranias, E. G.
Año de publicación
2006
Idioma
inglés
Tipo de recurso
reseña artículo
Estado
versión publicada
Descripción
The sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser16 site by PKA or the Thr17 site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca2+ uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca2+ load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser16 and Thr17 residues. Phosphorylation of the Thr17 residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca2+, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr17 residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca2+ and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr17 at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr17 mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr17 residue of PLN probably participates in a protective mechanism that favors Ca2+ handling and limits intracellular Ca2+ overload in pathological situations.
Facultad de Ciencias Médicas
Materia
Ciencias Médicas
isoprenaline
β-adrenergic stimulation
acidosis
ischemia
serine
threonine
phospholamban
Thr17 site phosphorylation
hypercapnia
pathophysiology
physiology
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc/3.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/37573

id SEDICI_2caa8ba35432335a9dfa0e0371aea3f2
oai_identifier_str oai:sedici.unlp.edu.ar:10915/37573
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditionsMattiazzi, Alicia RamonaMundiña-Weilenmann, CeciliaVittone, LeticiaSaid, María MatildeKranias, E. G.Ciencias Médicasisoprenalineβ-adrenergic stimulationacidosisischemiaserinethreoninephospholambanThr17 site phosphorylationhypercapniapathophysiologyphysiologyThe sarcoplasmic reticulum (SR) Ca<SUP>2+</SUP>-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser<SUP>16</SUP> site by PKA or the Thr<SUP>17</SUP> site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca<SUP>2+</SUP> uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca<SUP>2+</SUP> load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser<SUP>16</SUP> and Thr<SUP>17</SUP> residues. Phosphorylation of the Thr<SUP>17</SUP> residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca<SUP>2+</SUP>, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr<SUP>17</SUP> residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca<SUP>2+</SUP> and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr<SUP>17</SUP> at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr<SUP>17</SUP> mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr<SUP>17</SUP> residue of PLN probably participates in a protective mechanism that favors Ca<SUP>2+</SUP> handling and limits intracellular Ca<SUP>2+</SUP> overload in pathological situations.Facultad de Ciencias Médicas2006-05info:eu-repo/semantics/reviewinfo:eu-repo/semantics/publishedVersionRevisionhttp://purl.org/coar/resource_type/c_dcae04bcinfo:ar-repo/semantics/resenaArticuloapplication/pdf563-572http://sedici.unlp.edu.ar/handle/10915/37573enginfo:eu-repo/semantics/altIdentifier/url/http://www.scielo.br/pdf/bjmbr/v39n5/6159.pdfinfo:eu-repo/semantics/altIdentifier/issn/0100-879Xinfo:eu-repo/semantics/altIdentifier/doi/10.1590/S0100-879X2006000500001info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc/3.0/Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T10:57:03Zoai:sedici.unlp.edu.ar:10915/37573Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 10:57:04.193SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
spellingShingle The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
Mattiazzi, Alicia Ramona
Ciencias Médicas
isoprenaline
β-adrenergic stimulation
acidosis
ischemia
serine
threonine
phospholamban
Thr17 site phosphorylation
hypercapnia
pathophysiology
physiology
title_short The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_full The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_fullStr The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_full_unstemmed The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_sort The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
dc.creator.none.fl_str_mv Mattiazzi, Alicia Ramona
Mundiña-Weilenmann, Cecilia
Vittone, Leticia
Said, María Matilde
Kranias, E. G.
author Mattiazzi, Alicia Ramona
author_facet Mattiazzi, Alicia Ramona
Mundiña-Weilenmann, Cecilia
Vittone, Leticia
Said, María Matilde
Kranias, E. G.
author_role author
author2 Mundiña-Weilenmann, Cecilia
Vittone, Leticia
Said, María Matilde
Kranias, E. G.
author2_role author
author
author
author
dc.subject.none.fl_str_mv Ciencias Médicas
isoprenaline
β-adrenergic stimulation
acidosis
ischemia
serine
threonine
phospholamban
Thr17 site phosphorylation
hypercapnia
pathophysiology
physiology
topic Ciencias Médicas
isoprenaline
β-adrenergic stimulation
acidosis
ischemia
serine
threonine
phospholamban
Thr17 site phosphorylation
hypercapnia
pathophysiology
physiology
dc.description.none.fl_txt_mv The sarcoplasmic reticulum (SR) Ca<SUP>2+</SUP>-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser<SUP>16</SUP> site by PKA or the Thr<SUP>17</SUP> site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca<SUP>2+</SUP> uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca<SUP>2+</SUP> load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser<SUP>16</SUP> and Thr<SUP>17</SUP> residues. Phosphorylation of the Thr<SUP>17</SUP> residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca<SUP>2+</SUP>, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr<SUP>17</SUP> residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca<SUP>2+</SUP> and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr<SUP>17</SUP> at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr<SUP>17</SUP> mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr<SUP>17</SUP> residue of PLN probably participates in a protective mechanism that favors Ca<SUP>2+</SUP> handling and limits intracellular Ca<SUP>2+</SUP> overload in pathological situations.
Facultad de Ciencias Médicas
description The sarcoplasmic reticulum (SR) Ca<SUP>2+</SUP>-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser<SUP>16</SUP> site by PKA or the Thr<SUP>17</SUP> site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca<SUP>2+</SUP> uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca<SUP>2+</SUP> load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser<SUP>16</SUP> and Thr<SUP>17</SUP> residues. Phosphorylation of the Thr<SUP>17</SUP> residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca<SUP>2+</SUP>, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr<SUP>17</SUP> residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca<SUP>2+</SUP> and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr<SUP>17</SUP> at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr<SUP>17</SUP> mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr<SUP>17</SUP> residue of PLN probably participates in a protective mechanism that favors Ca<SUP>2+</SUP> handling and limits intracellular Ca<SUP>2+</SUP> overload in pathological situations.
publishDate 2006
dc.date.none.fl_str_mv 2006-05
dc.type.none.fl_str_mv info:eu-repo/semantics/review
info:eu-repo/semantics/publishedVersion
Revision
http://purl.org/coar/resource_type/c_dcae04bc
info:ar-repo/semantics/resenaArticulo
format review
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/37573
url http://sedici.unlp.edu.ar/handle/10915/37573
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://www.scielo.br/pdf/bjmbr/v39n5/6159.pdf
info:eu-repo/semantics/altIdentifier/issn/0100-879X
info:eu-repo/semantics/altIdentifier/doi/10.1590/S0100-879X2006000500001
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc/3.0/
Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc/3.0/
Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)
dc.format.none.fl_str_mv application/pdf
563-572
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1844615831793696768
score 13.070432